GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » NextTrip Inc (NAS:NTRP) » Definitions » Cash, Cash Equivalents, Marketable Securities

NextTrip (NextTrip) Cash, Cash Equivalents, Marketable Securities : $0.56 Mil (As of Sep. 2023)


View and export this data going back to 2017. Start your Free Trial

What is NextTrip Cash, Cash Equivalents, Marketable Securities?

NextTrip's quarterly cash, cash equivalents, marketable securities declined from Mar. 2023 ($1.49 Mil) to Jun. 2023 ($0.37 Mil) but then increased from Jun. 2023 ($0.37 Mil) to Sep. 2023 ($0.56 Mil).

NextTrip's annual cash, cash equivalents, marketable securities increased from Dec. 2020 ($3.70 Mil) to Dec. 2021 ($11.45 Mil) but then declined from Dec. 2021 ($11.45 Mil) to Dec. 2022 ($2.85 Mil).


NextTrip Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for NextTrip's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextTrip Cash, Cash Equivalents, Marketable Securities Chart

NextTrip Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.28 0.09 3.70 11.45 2.85

NextTrip Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.80 2.85 1.49 0.37 0.56

NextTrip Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


NextTrip  (NAS:NTRP) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


NextTrip Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of NextTrip's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


NextTrip (NextTrip) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » NextTrip Inc (NAS:NTRP) » Definitions » Cash, Cash Equivalents, Marketable Securities
Traded in Other Exchanges
N/A
Address
3900 Paseo del Sol, Santa Fe, NM, USA, 87507
Sigma Additive Solutions Inc is a leading provider of in-process quality assurance (IPQA) software to the additive manufacturing industry. Sigma specializes in the development and commercialization of real-time monitoring and analytics solutions known as PrintRite3D for 3D metal and polymer advanced manufacturing technologies. Its principal business activities include the development of its In-Process Quality Assurance (IPQA) suite of technologies and the commercialization of both its IPQA and materials-related suite of technologies, with its focus on three-dimensional printing (3DP) industry.
Executives
Mark Ruport director, officer: Executive Chairman 5575 MARK DABLING BLVD, SUITE 100, COLORADO SPRINGS CO 80919
Stephan Kuehr officer: GM of European Operations LEONHARDYWEG 30, BERLIN 2M 10121
Jacob Brunsberg officer: Sr VP Product Mgt/Strat Rel 3900 PASEO DEL SOL, SANTA FE NM 87507
Carl I. Schwartz 10 percent owner 20155 N.E. 38TH COURT, UNIT 3104, AVENTURA FL 33180
Frank Orzechowski officer: CFO, PFO and PAO 3900 PASEO DEL SOL, SANTA FE NM 87507
Darren Beckett officer: Vice President of Engineering 3900 PASEO DEL SOL, SANTA FE NM 87507
Kent J Summers director 13 ONONDAGA LANE, MEDFIELD MA 02052
Mark Cola director, officer: President, CEO and COO 3900 PASEO DEL SOL, SANTA FE NM 87507
Nannette Toups officer: CFO, PFO and PAO C/O SIGMA LABS, INC., 3900 PASEO DEL SOL, SANTA FE NM 87507
Salvatore F Battinelli director 5 CLIFTON AVENUE, MARBLEHEAD MA 01945
Dennis Duitch director 150 E PALMETTO PARK ROAD, SUITE 510, BOCA RATON FL 33432
John Reynolds Rice director 3900 PASEO DEL SOL, SANTA FE NM 87507
Fisher Ronald Kenneth Jr officer: Vice President of Business Dev 3900 PASEO DEL SOL, SANTA FE NM 87507
Frank J Garofalo director 3900 PASEO DEL SOL, SANTA FE NM 87507
Amanda Cola officer: VP of Finance and Business Ops 3900 PASEO DEL SOL, SANTA FE NM 87507

NextTrip (NextTrip) Headlines

From GuruFocus

Neurotrope to Participate in the BIO CEO & Investor Conference

By PRNewswire PRNewswire 02-08-2019